Skip to main content
UniHealth

Doctor search

Richard David Mamelok, MD

Internal Medicine · Palo Alto

NPI 1942624192

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mamelok’s office at (650) 924-0347 to ask if they take your plan before you enroll.

California Medical Board record

Licence G33270 · Current

Licensed to practise in California · since 1976 · expires 2028-03-31 · Dartmouth Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine

Money from drug and device companies

$6,400 in 2022

Industry payments by year
202214$6,400$6,400
202113$2,905$2,905
202036$11,480$11,480
2019316$15,163$15,163

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Urovant SciencesGemtesa$6,400
4 payments
  • Consulting · 2022-12-08 · $600
  • Consulting for Gemtesa · 2022-06-03 · $1,800
  • Consulting for Gemtesa · 2022-04-20 · $3,300
  • Consulting · 2022-04-13 · $700
See all 4 published payments
Every published payment
Urovant SciencesConsulting · 2022-12-08None$600
Urovant SciencesConsulting · 2022-06-03Gemtesa$1,800
Urovant SciencesConsulting · 2022-04-20Gemtesa$3,300
Urovant SciencesConsulting · 2022-04-13None$700
See earlier years (2021, 2020, 2019)

2021: $2,905

Payments by company in 2021
DermiraQbrexza$2,905
3 payments
  • Consulting for Qbrexza · 2021-04-30 · $1,141
  • Consulting for Qbrexza · 2021-04-06 · $934
  • Consulting for Qbrexza · 2021-02-22 · $830

2020: $11,480

Payments by company in 2020
DermiraQbrexza$6,343
3 payments
  • Consulting for Qbrexza · 2020-06-26 · $5,499
  • Consulting for Qbrexza · 2020-06-08 · $656
  • Consulting for Qbrexza · 2020-03-23 · $188
AllerganFetzima$4,500
2 payments
  • Consulting for Fetzima · 2020-06-09 · $1,238
  • Consulting for Fetzima · 2020-06-02 · $3,263
ExelixisCabozantinib$638
1 payment
  • Consulting for Cabozantinib · 2020-07-15 · $638

2019: $15,163

Payments by company in 2019
DermiraQbrexza$12,563
12 payments
  • Consulting for Qbrexza · 2019-12-16 · $281
  • Consulting for Qbrexza · 2019-11-25 · $375
  • Consulting for Qbrexza · 2019-09-24 · $188
  • Consulting for Qbrexza · 2019-08-19 · $563
  • Consulting for Qbrexza · 2019-07-19 · $938
  • Consulting for Qbrexza · 2019-06-17 · $938
  • Consulting for Qbrexza · 2019-05-13 · $656
  • Consulting for Qbrexza · 2019-04-15 · $1,688
  • Consulting for Qbrexza · 2019-03-18 · $2,531
  • Consulting for Qbrexza · 2019-03-18 · $1,406
  • Consulting for Qbrexza · 2019-02-11 · $2,625
  • Consulting for Qbrexza · 2019-02-11 · $375
AllerganBotox$2,388
3 payments
  • Consulting for Botox · 2019-04-02 · $1,750
  • Consulting for Botox · 2019-04-02 · $319
  • Consulting for Botox · 2019-04-02 · $319
ExelixisCabozantinib$213
1 payment
  • Consulting for Cabozantinib · 2019-10-16 · $213

Professional record

NPI
1942624192
Licence
CA G33270California G33270: Current · expires 2028-03-31
More record details
Sole proprietor
Yes
Taxonomy
Internal medicine (207R00000X)
Mailing address
364 Churchill Ave, Palo Alto, CA, 94301
NPI first listed
2014-02-08
NPI last updated
2014-02-08

This is when the NPI record was last certified, not a medical board exam.